tiprankstipranks
Kintor Pharma Advances AGA Treatment Trials
Company Announcements

Kintor Pharma Advances AGA Treatment Trials

Kintor Pharmaceutical Ltd (HK:9939) has released an update.

Don't Miss our Black Friday Offers:

Kintor Pharmaceutical Limited has announced the approval of a clinical trial for KX-826 tincture 1.0%, a treatment for male adult androgenetic alopecia (AGA) in China, by the National Medical Products Administration (NMPA). This trial will assess the efficacy and safety of the tincture, which has shown promising results in preclinical studies and previous trials in China and the U.S. The company is also engaging in further clinical research to investigate the potential of KX-826 in dermatology, including treatments for AGA and acne.

For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App